Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,476 | -13,562 | -9,484 | -6,013 | -2,891 |
| Depreciation Amortization | 17 | 1,546 | 294 | 188 | 87 |
| Other Working Capital | 74 | 259 | 439 | -216 | -431 |
| Other Operating Activity | 200 | 737 | 557 | 389 | 248 |
| Operating Cash Flow | $-3,184 | $-11,020 | $-8,194 | $-5,651 | $-2,987 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -347 | -347 | -321 | -66 |
| Investing Cash Flow | $-1 | $-347 | $-347 | $-321 | $-66 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -89 | -88 | -88 | -87 |
| Common Stock Issued | N/A | 7,869 | 2,963 | 2,941 | 2,935 |
| Other Financing Activity | 0 | 2,149 | -116 | -13 | 0 |
| Financing Cash Flow | $-1 | $9,929 | $2,759 | $2,840 | $2,848 |
| Beginning Cash Position | 10,061 | 11,500 | 11,500 | 11,500 | 11,445 |
| End Cash Position | 6,875 | 10,061 | 5,717 | 8,368 | 11,238 |
| Net Cash Flow | $-3,186 | $-1,438 | $-5,782 | $-3,132 | $-206 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,184 | -11,020 | -8,194 | -5,651 | -2,987 |
| Capital Expenditure | -1 | -347 | -347 | -321 | -66 |
| Free Cash Flow | -3,186 | -11,367 | -8,541 | -5,972 | -3,054 |